Results
AstraZeneca India FY26 Revenue Up 33% to ₹22.8 Billion
AstraZeneca Pharma India reported 33% YoY revenue growth to ₹22,756 million and 62% net profit increase to ₹1,875 million, driven by strong Oncology segment performance.
The company declared a final d
